AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Geriatr Psychiatry 14:343-351, April 2006
© 2006 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borroni, B.
Right arrow Articles by Padovani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borroni, B.
Right arrow Articles by Padovani, A.

Article

Cumulative Effect of COMT and 5-HTTLPR Polymorphisms and Their Interaction With Disease Severity and Comorbidities on the Risk of Psychosis in Alzheimer Disease

Barbara Borroni, M.D., Mario Grassi, Ph.D., Chiara Agosti, M.D., Silvana Archetti, Ph.D., Chiara Costanzi, M.D., Cristina Cornali, M.D., Carlo Caltagirone, M.D., Luigi Caimi, M.D., Monica Di Luca, Ph.D., and Alessandro Padovani, M.D., Ph.D.

From the Centre for Ageing Brain and Dementia, Department of Neurology, University of Brescia, Brescia, Italy (BB, CA, C. Costanzi, AP), the Department of Health Sciences, Section of Medical Statistics & Epidemiology (MG) and III Laboratory of Biotechnology (SA, LC), University of Brescia, Brescia, Italy, the Alzheimer Centre, Palazzolo S/O, Brescia, Brescia, Italy (C. Cornali), the Department of Neurology, IRCCS "S. Lucia," University "Tor Vergata," Rome, Italy (C. Caltagirone), and the Centre of Excellence for Neurodegenerative Disorders and Department of Pharmacological Sciences, University of Milan, Milan, Italy (MD).

Objective: The objective of this study was to investigate the cumulative effect of the genes likely involved in Alzheimer disease (AD)-related psychosis and their interaction with disease stage and environmental factors.

Methods: Two hundred thirty-four patients with AD underwent clinical and neuropsychologic examination, behavioral and psychiatric disturbances evaluation, and were subsequently divided into two subgroups according to the presence (AD-P) or the absence (AD-nP) of psychotic symptoms. Cathecol-O-methyltransferase (COMT), serotonin gene-linked promoter region (5-HTTLPR), and Apolipoprotein E (ApoE) genotypes were performed.

Results: COMT*H (H/H or H/liter; odds ratio [OR]: 2.4; 95% confidence interval [CI]: 1.13–5.11) and 5-HTTLPR*S (S/S or S/liter, OR: 2.14; 95% CI: 1.13–4.07) were associated with AD-P. A gene dose effect was observed; in fact, carriers of both polymorphisms showed a fivefold risk for psychosis compared with patients bearing no polymorphisms. An interaction between these two genetic variations with disease stage and ischemic cardiomyopathy was found, the latter influencing AD-P risk only if "at-risk" genetic polymorphisms were present. The combined trend effect of COMT*H plus 5-HTTLPR*S and advance disease stage on AD-P risk was approximately 200% greater than that predicted by assuming additive effects, whereas the one obtained by COMT*H plus 5-HTTLPR*S and ischemic cardiomyopathy was 50% greater. ApoE genotype did not influence AD-P risk.

Conclusions: These findings claim for a synergic effect of COMT*H and 5-HTTLPR*S polymorphisms on the risk of psychosis in AD and for their interaction with disease stage and ischemic cardiomyopathy. This study suggests that considering both the genetic background and the environmental correlates might provide new insight for understanding psychosis mechanisms related to AD.

Key Words: Alzheimer disease • psychosis • COMT • 5-HTTLPR • polymorphism






HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2006 American Association for Geriatric Psychiatry